Thomas Hager

Metastatic Malignant Melanoma With Complete Loss of Differentiation Markers (Undifferentiated/Dedifferentiated Melanoma)

Abbas Agaimy, Katja Specht, Robert Stoehr et al. · The American Journal of Surgical Pathology · 2015 · 134 citations

Pathology, Dermatology, Tumor Biology +16

MET Expression in Advanced Non–Small-Cell Lung Cancer: Effect on Clinical Outcomes of Chemotherapy, Targeted Therapy, and Immunotherapy

Henning Reis, Martin Metzenmacher, Moritz Goetz et al. · Clinical Lung Cancer · 2018 · 106 citations

Met Expression, Medicine, Metronomic Therapy +8

Comparing the Prognostic Value of BAP1 Mutation Pattern, Chromosome 3 Status, and BAP1 Immunohistochemistry in Uveal Melanoma

Johannes A.P. van de Nes, Jasmin Nelles, Stefan Kreis et al. · The American Journal of Surgical Pathology · 2016 · 99 citations

Somatic Variant, Gene Dosage Analysis, Medicine +14

Different micro-RNA expression profiles distinguish subtypes of neuroendocrine tumors of the lung: results of a profiling study

Fabian Mairinger, Saskia Ting, Robert A. Werner et al. · Modern Pathology · 2014 · 78 citations · Full text

Tumor Biology, Tumor Heterogeneity, Profiling Study +11

High Prevalence of Concomitant Oncogene Mutations in Prospectively Identified Patients with ROS1-Positive Metastatic Lung Cancer

Marcel Wiesweg, Wilfried Eberhardt, Henning Reis et al. · Journal of Thoracic Oncology · 2016 · 68 citations

Oncology, Somatic Variant, Concomitant Oncogene Mutations +10